Filing Details
- Accession Number:
- 0001209191-19-047582
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-08-28 13:01:43
- Reporting Period:
- 2019-08-26
- Accepted Time:
- 2019-08-28 13:01:43
- Original Submission Date:
- 2019-08-28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1469443 | Arcadia Biosciences Inc. | RKDA | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1326765 | T Matthew Plavan | C/O Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis CA 95618 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-26 | 1,000 | $8.33 | 1,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-26 | 1,000 | $9.22 | 2,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-27 | 1,000 | $9.32 | 3,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-27 | 1,000 | $9.30 | 4,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-27 | 1,000 | $8.95 | 5,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-27 | 2,000 | $8.93 | 7,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-28 | 1,000 | $6.88 | 8,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
